Orion Portfolio Solutions’s Castle Biosciences CSTL Stock Holding History

Orion Portfolio Solutions’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.57M	Buy	78,409 +10,093	+15%	+$250K	0.02%	836
2024 Q4	$1.82M	Sell	68,316 -4,089	-6%	-$125K	0.02%	751
2024 Q3	$2.06M	Buy	72,405 +10,324	+17%	+$263K	0.02%	673
2024 Q2	$1.35M	Sell	62,081 -5,156	-8%	-$115K	0.01%	836
2024 Q1	$1.49M	Sell	67,237 -2,496	-4%	-$54.3K	0.02%	798
2023 Q4	$1.53M	Sell	69,733 -4,294	-6%	-$75.6K	0.02%	759
2023 Q3	$1.25M	Sell	74,027 -3,523	-5%	-$61.6K	0.02%	824
2023 Q2	$1.06M	Buy	77,550 +47,885	+161%	+$970K	0.01%	927
2023 Q1	$674K	Buy	+29,665	New	+$725K	0.01%	1031

Other funds holding CSTL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Orion Portfolio Solutions's CSTL Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Castle Biosciences (CSTL) stake by 15% in Q1 2025, buying an estimated $250K and bringing the position to 78,409 shares worth $1.57M. The position accounts for 0.02% of the portfolio, ranked #836.

Orion Portfolio Solutions first reported a position in CSTL in Q1 2023 and has held it in 9 quarters since. The position peaked at $2.06M in Q3 2024. 180 funds tracked by Wall St. Rank hold CSTL as of Q1 2025.

Orion Portfolio Solutions held 78,409 shares of Castle Biosciences worth $1.57M as of Q1 2025.
Orion Portfolio Solutions bought 10,093 Castle Biosciences shares in Q1 2025, an estimated $250K.
Castle Biosciences made up 0.02% of Orion Portfolio Solutions's portfolio in Q1 2025, its #836 holding.
Orion Portfolio Solutions first reported a position in Castle Biosciences in Q1 2023 and has held it in 9 quarters since.
Orion Portfolio Solutions's Castle Biosciences position peaked at $2.06M in Q3 2024.
180 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.